Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.32255 | 52 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.3044 | 53 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.3104 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.17521 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.18786 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.44376 | 54 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.32506 | 51 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.40041 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.27931 | 53 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.29628 | 53 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.29006 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.25056 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.27774 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.29772 | 53 |